Organon & Co | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
Bristol-Myers Squibb USD 494M 2M 2025-03
Celltrion KRW 18.38B 907.05M 2024-09
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Dianthus Therapeutics 4.44M 263K 2024-09
Ecofibre AUD 761K 773K 2024-06
Gilead Sciences USD 260M 12M 2025-03
Glaxosmithkline 178.05M 24.73M 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Medical Developments International AUD 21K 23K 2024-06
Merck USD 328M 2M 2024-12
Neuren Pharmaceuticals 0 0 2024-06
Novartis USD 275M 11M 2024-12
Organon & Co USD 132M 6M 2024-12
Qiagen NV USD 11.14M 337K 2024-12
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 7.77M 2.08M 2024-11



Organon & Co Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.